Stanford Cancer Institute - Stanford Cancer Center Palo Alto — Palo Alto, California

Stanford Cancer Institute - Stanford Cancer Center Palo Alto is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute - Stanford Cancer Center Palo Alto has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Melanoma.

Sponsors: Immunocore Ltd.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute - Stanford Cancer Center Palo Alto?

Stanford Cancer Institute - Stanford Cancer Center Palo Alto has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute - Stanford Cancer Center Palo Alto conducted?

Stanford Cancer Institute - Stanford Cancer Center Palo Alto has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Melanoma.

Is Stanford Cancer Institute - Stanford Cancer Center Palo Alto accredited by Crixeo Clinical Trials?

Stanford Cancer Institute - Stanford Cancer Center Palo Alto has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute - Stanford Cancer Center Palo Alto?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.